Private Advisors LLC cut its stake in shares of Teligent Inc (NASDAQ:TLGT) by 11.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 172,408 shares of the company’s stock after selling 21,833 shares during the period. Private Advisors LLC’s holdings in Teligent were worth $200,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in TLGT. Rhumbline Advisers grew its holdings in shares of Teligent by 47.3% during the fourth quarter. Rhumbline Advisers now owns 55,390 shares of the company’s stock worth $76,000 after buying an additional 17,792 shares in the last quarter. SG Americas Securities LLC acquired a new position in Teligent in the fourth quarter valued at about $60,000. Raymond James & Associates lifted its position in Teligent by 21.9% in the fourth quarter. Raymond James & Associates now owns 36,700 shares of the company’s stock valued at $50,000 after buying an additional 6,600 shares during the last quarter. GSA Capital Partners LLP acquired a new position in Teligent in the fourth quarter valued at about $192,000. Finally, Elk Creek Partners LLC lifted its position in Teligent by 6.0% in the fourth quarter. Elk Creek Partners LLC now owns 4,880,589 shares of the company’s stock valued at $6,686,000 after buying an additional 277,834 shares during the last quarter. 62.93% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts have commented on the stock. ValuEngine cut shares of Teligent from a “buy” rating to a “hold” rating in a research report on Thursday, May 23rd. Raymond James cut shares of Teligent from a “strong-buy” rating to an “outperform” rating in a research report on Tuesday, March 19th.
Shares of TLGT traded down $0.01 during mid-day trading on Friday, hitting $0.55. 204,491 shares of the company’s stock were exchanged, compared to its average volume of 365,759. The stock has a market capitalization of $29.60 million, a PE ratio of -1.67 and a beta of 1.67. Teligent Inc has a fifty-two week low of $0.54 and a fifty-two week high of $4.52. The company has a debt-to-equity ratio of 14.43, a quick ratio of 0.79 and a current ratio of 1.46.
Teligent (NASDAQ:TLGT) last issued its quarterly earnings results on Monday, March 18th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($0.16). The business had revenue of $16.78 million for the quarter, compared to analyst estimates of $17.73 million. Teligent had a negative return on equity of 103.41% and a negative net margin of 73.56%. On average, sell-side analysts predict that Teligent Inc will post -0.17 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://www.dispatchtribunal.com/2019/06/16/private-advisors-llc-sells-21833-shares-of-teligent-inc-nasdaqtlgt.html.
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.
Further Reading: Margin
Want to see what other hedge funds are holding TLGT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teligent Inc (NASDAQ:TLGT).
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.